Lethal poisonings with AH-7921 in combination with other substances

Forensic Science International

Volumn 244, Issue , 2014, Pages e21-e24

  Karinen, Ritva ^a   Tuv, Silja Skogstad ^a   Rogde, Sidsel ^a,b   Peres, Mariana Dadalto ^c   Johansen, Unni ^a   Frost, Joachim ^d   Vindenes, Vigdis ^a   Øiestad, Åse Marit Leere ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

AH 7921; Designer drugs; Forensic science; UPLC MS MS; Whole blood

Indexed keywords

2 FLUOROMETHAMPHETAMINE; 3 METHYLMETCATHINON; 4 FLUOROMETHAMPHETAMINE; 7 AMINO 1,3 DIHYDRO 5 PHENYL 2H 1,4 BENZODIAZEPIN 2 ONE; AH 7921; CODEINE; CODEINE 6 GLUCURONIDE; DIAZEPAM; ETIZOLAM; ILLICIT DRUG; METHOXETAMINE; NORDAZEPAM; OXAZEPAM; PARACETAMOL; PHENAZEPAM; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG; ANALGESIC AGENT; BENZAMIDE DERIVATIVE; NARCOTIC AGENT;

ADULT; ARTICLE; AUTOPSY; BLOOD ANALYSIS; CASE REPORT; CAUSE OF DEATH; FATALITY; FEMALE; FORENSIC PATHOLOGY; FORENSIC TOXICOLOGY; HUMAN; INTERNET; INTOXICATION; LUNG EDEMA; MALE; PAIN; ADDICTION; BLOOD; YOUNG ADULT;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; BENZAMIDES; FEMALE; FORENSIC TOXICOLOGY; HUMANS; MALE; NARCOTICS; PSYCHOTROPIC DRUGS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84911045078     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2014.08.013     Document Type: Article

References (31)

1. Brandt S.D., King L.A., Evans-Brown M. The new drug phenomenon. Drug Test. Anal. 2014, 6:587-597.
2. Park B.K., Kitteringham N.R., O'Neill P.M. Metabolism of fluorine-containing drugs. Annu. Rev. Pharmacol. Toxicol. 2001, 41:443-470.
3. New drugs in Europe. EMCDDA-Europol 2012 Annual Report on the Implementation of Council Decision 2005/387/JHA 2012, http://www.emcdda.europa.eu/attachements.cfm/att_212366_EN_EMCDDA-Europol%202012%20Annual%20Report_final.pdf (accessed 18.07.13).
4. Elliott S., Evans J. A 3-year review of new psychoactive substances in casework. Forensic Sci. Int. 2014, 243C:55-60.
5. Gibbons S. 'Legal highs' - novel and emerging psychoactive drugs: a chemical overview for the toxicologist. Clin. Toxicol. (Phila.) 2012, 50:15-24.
6. Uchiyama N., Matsuda S., Kawamura M., Kikura-Hanajiri R., Goda Y. Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products. Forensic Toxicol. 2013, 31:1-18.
7. Harper N.J., Veitch G.B., Wibberley D.G. 1-(3,4-Dichlorobenzamidomethyl)cyclohexyldimethylamine and related compounds as potential analgesics. J. Med. Chem. 1974, 17:1188-1193.
8. Ujváry I. AH-7921, Technical Description 2013, Information note on AH-7921.pdf. https://ednd.emcdda.europa.eu/assets/upload/showfile?filename=EMCDDA (accessed 28.10.13).
9. Brittain R.T., Kellett D.N., Neat M.L., Stables R. Proceedings: anti-nociceptive effects in N-substituted cyclohexylmethylbenzamides. Br. J. Pharmacol. 1973, 49:158P-159P.
10. Tyers M.B. A classification of opiate receptors that mediate antinociception in animals. Br. J. Pharmacol. 1980, 69:503-512.
11. Hayes A.G., Tyers M.B. Determination of receptors that mediate opiate side effects in the mouse. Br. J. Pharmacol. 1983, 79:731-736.
12. Øiestad E.L., Johansen U., Øiestad A.M., Christophersen A.S. Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 2011, 35:280-293.
13. Dahl S.R., Olsen K.M., Strand D.H. Determination of gamma-hydroxybutyrate (GHB), beta-hydroxybutyrate (BHB), pregabalin, 1,4-butane-diol (1,4BD) and gamma-butyrolactone (GBL) in whole blood and urine samples by UPLC-MSMS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2012, 885-886:37-42.
14. Kristoffersen L., Stormyhr L.-E., Smith-Kielland A. Headspace gas chromatographic determination of ethanol: the use of factorial design to study effects of blood storage and headspace conditions on ethanol stability and acetaldehyde formation in whole blood and plasma. Forensic Sci. Int. 2006, 161:151-157.
15. Broecker S., Herre S., Wust B., Zweigenbaum J., Pragst F. Development and practical application of a library of CID accurate mass spectra of more than 2,500 toxic compounds for systematic toxicological analysis by LC-QTOF-MS with data-dependent acquisition. Anal. Bioanal. Chem. 2011, 400:101-117.
16. White J.M., Irvine R.J. Mechanisms of fatal opioid overdose. Addiction 1999, 94:961-972.
17. Kronstrand R., Thelander G. Designer Drug(s) Involved: AH-7921 (3,4-Dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) 2013, http://www.soft-tox.org/files/Designer_Drugs/AH_7921_January_2013.pdf (accessed 07.08.13).
18. Vorce S.P., Knittel J.L., Holler J.M., Magluilo J., Levine B., Berran P., Bosy T.Z. A fatality involving AH-7921. J. Anal. Toxicol. 2014, 38:226-230.
19. Mogri M., Khan M.I.A., Grant B.J.B., Mador M.J. Central sleep apnea induced by acute ingestion of opioids. CHEST J. 2008, 133:1484-1488.
20. Lotsch J., Skarke C., Schmidt H., Rohrbacher M., Hofmann U., Schwab M., Geisslinger G. Evidence for morphine-independent central nervous opioid effects after administration of codeine: contribution of other codeine metabolites. Clin. Pharmacol. Ther. 2006, 79:35-48.
21. Kesha K., Boggs C.L., Ripple M.G., Allan C.H., Levine B., Jufer-Phipps R., Doyon S., Chi P., Fowler D.R. Methylenedioxypyrovalerone ("bath salts"), related death: case report and review of the literature. J. Forensic Sci. 2013, 58:1654-1659.
22. Fracasso C., Confalonieri S., Garattini S., Caccia S. Single and multiple dose pharmacokinetics of etizolam in healthy subjects. Eur. J. Clin. Pharmacol. 1991, 40:181-185.
23. Fukasawa T., Yasui-Furukori N., Suzuki A., Inoue Y., Tateishi T., Otani K. Pharmacokinetics and pharmacodynamics of etizolam are influenced by polymorphic CYP2C19 activity. Eur. J. Clin. Pharmacol. 2005, 61:791-795.
24. Zherdev V.P., Caccia S., Garattini S., Ekonomov A.L. Species differences in phenazepam kinetics and metabolism. Eur. J. Drug Metab. Pharmacokinet. 1982, 7:191-196.
25. Kriikku P., Wilhelm L., Rintatalo J., Hurme J., Kramer J., Ojanpera I. Phenazepam abuse in Finland: findings from apprehended drivers, post-mortem cases and police confiscations. Forensic Sci. Int. 2012, 220:111-117.
26. Ward J., Rhyee S., Plansky J., Boyer E. Methoxetamine: a novel ketamine analog and growing health-care concern. Clin. Toxicol. (Phila.) 2011, 49:874-875.
27. Wikstrom M., Thelander G., Dahlgren M., Kronstrand R. An accidental fatal intoxication with methoxetamine. J. Anal. Toxicol. 2013, 37:43-46.
28. Elian A.A., Hackett J. A polydrug intoxication involving methoxetamine in a drugs and driving case. J. Forensic Sci. 2014, 59:854-858.
29. Lukasik-Glebocka M., Sommerfeld K., Tezyk A., Zielinska-Psuja B., Druzdz A. Acute methoxetamine intoxication - a case report with serum and urine concentrations. Przegl. Lek. 2013, 70:671-673.
30. Sein Anand J., Wiergowski M., Barwina M., Kaletha K. Accidental intoxication with high dose of methoxetamine (MXE) - a case report. Przegl. Lek. 2012, 69:609-610.
31. Wood D.M., Davies S., Puchnarewicz M., Johnston A., Dargan P.I. Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. Eur. J. Clin. Pharmacol. 2012, 68:853-856.